MLE-301

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameMLE-301

Drug Alias NameNK3R antagonist (Millendo Therapeutics)Neurokinin 3 Receptor Antagonist (Millendo Therapeutics)neurokinin 3 receptor antagonist (Millendo Therapeutics)MLE-301

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNeurokinin 3 receptor antagonists

TargetsNeurokinin 3 receptor

Therapy Area/IndicationsMenopausal symptoms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesMillendo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesMillendo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMenopausal symptoms

Inactive IndicationsN/A

Other Information

ATC CodeN/A